After a slow 2020, biotech dealmaking in 2021 is off to a good start. However, the industry is experiencing profound changes.
Here’s why Venture Capital firms are investing billions in Asian healthcare and technology companies.
A rising middle class, government support and private investment are fueling the rise of biotechnology in India.
Private Equity and Hedge Funds are terms that refer to two distinct things.